Latest News and Press Releases
Want to stay updated on the latest news?
Search Results
Everything
Search Filters
-
MORRISTOWN, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (“Melinta”), a commercial-stage company focused on the development and commercialization of novel antibiotics, today...
-
CHAPEL HILL, N.C., Nov. 03, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and...
-
NEW HAVEN, Conn. and CHAPEL HILL, N.C., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc., a privately held company developing and commercializing novel antibiotics to treat serious...
-
NEW HAVEN, Conn. and CHAPEL HILL, N.C., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc., a privately held company developing and commercializing novel antibiotics to treat serious...
-
CHAPEL HILL, N.C. and NEW HAVEN, Conn., Sept. 28, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives...
-
CHAPEL HILL, N.C., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and...
-
—Broad pipeline and resources provide multiple opportunities to drive long-term value creation— —Merger lays strong foundation for launch of recently FDA-approved Baxdela™ (delafloxacin)— ...
-
CHAPEL HILL, N.C., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and...
-
CHAPEL HILL, N.C., July 20, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and...
-
CHAPEL HILL, N.C., June 02, 2017 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP), a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the...